HIF-1α dependent RhoA as a novel therapeutic target to regulate rheumatoid arthritis fibroblast-like synoviocytes migration in vitro and in vivo

• Published in: Journal of orthopaedic translation Vol. 40; pp. 49 - 57
• Main Authors: Chen, Jianhai, Chen, Jingqin, Tan, Jianwei, Li, Jian, Cheng, Wenxiang, Ke, Liqing, Wang, Qijing, Wang, Anqiao, Lin, Sien, Li, Gang, Zhang, Peng, Wang, Benguo
• Format: Journal Article
• Language: English
• Published: Singapore Elsevier B.V 01.05.2023; Chinese Speaking Orthopaedic Society; Elsevier
• Subjects: Hypoxia; Migration; Original; Rheumatoid arthritis; RhoA; Hypoxia; Migration; Rheumatoid arthritis; RhoA
• ISSN: 2214-031X; 2214-0328
• DOI: 10.1016/j.jot.2023.05.004

The purpose of this work is to investigate how the Rho family of GTPases A (RhoA) mediates the pathogenesis of rheumatoid arthritis fibroblast-like synoviocytes (RA-FLS). The expression of RhoA in the synovial tissues of RA and Healthy people (Control) was detected using immunohistochemistry methods. The expression of RhoA and hypoxia-inducible factor-1α (HIF-1α) is inhibited by small interfering RNAs (siRNAs). The inhibition effect on RA-FLS migration was further investigated. The protein expression level of HIF-1α, RhoA, focal adhesion kinase (FAK), and myosin light chain (MLC) was also analysed using western blotting (WB). DBA1 mice were immunised with the mixture of bovine type II collagen and Freund's adjuvant to establish collagen induced arthritis (CIA) mouse model. Lip-siRhoA is administered through joint injection every two days. Micro-computed tomography (micro-CT) was used to detect mouse ankle joint destruction and evaluate the bone loss of the periarticular side. Destruction of the ankle articular cartilage was tested by histology. Expressions of P-RhoA, P-FAK and P-MLC in the ankle joint was detected by immunohistochemistry assay. The expression level of RhoA in the synovial tissues of RA patients was significantly higher than that in control group. Hypoxia was able to up-regulate the expression of RhoA. Whereas, HIF-1α siRNA (siHIF-1α) could down-regulate the expression of RhoA. Additionally, both of siHIF-1α and RhoA siRNA (siRhoA) delivered by liposome (Lip-siHIF-1α and Lip-siRhoA) were found to suppress FAK and MLC phosphorylation in vitro. In CIA mouse model, Lip-siRhoA was demonstrated to ameliorate the destruction of ankle joint and reduce the severity of ankle joint cartilage damage by micro-CT and histological staining, respectively. Therefore, inhibition of FLS cell migration can protect articular bone from destruction. Furthermore, the expression of P-RhoA, P-FAK and P-MLC was evaluated and found to be down-regulated by Lip-siRhoA in vivo. The results demonstrated that under hypoxic environment, HIF-1α dependent RhoA pathway played an important role on cytoskeleton remodelling and RA-FLS migration. Through down-regulating RhoA expression, it could effectively treat RA in vitro and in vivo. Our study provides new evidence for the potential clinical application of RhoA as a candidate for the treatment of RA. HIF-1α mediates RhoA to regulate RA-FLS cell migration under hypoxic environment. Hypoxia causes HIF-1α to stabilize and then enter the cell to promote RhoA mRNA transcription. RhoA further promote FAK and MLC phosphorylation, leading to actin polymerization, cell magration, actin-myosin contractility, and the formation of focal adhesions. [Display omitted]